Antihypertensive drug classes and risk of incident dementia: a multinational population-based cohort study
Age and Ageing · 2025
DOI: 10.1093/ageing/afaf121 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Age and Ageing, 2025. Verfasst von Edmund C L Cheung und 17 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Ko…. Hauptthemen laut MEDLINE: Antihypertensive Agents, Dementia, Angiotensin-Converting Enzyme Inhibitors, Hypertension. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Demenz
Abstract (Originalsprache)
Background
Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin-II receptor blockers (ARBs) are first-line antihypertensive drugs for many patients, and influencing angiotensin systems may play a role in dementia risk. This study aimed to investigate whether exposure to different antihypertensive drug classes compared with ACEI affects the risk of dementia and pathological dementia subtypes in a large multinational database study.
Methods
This was a multinational population-based cohort study using electronic health databases in Hong Kong, the UK, Sweden and Australia. A common protocol was used to harmonise the study design. An active comparator, a new user design, was applied to compare the risk of all-cause dementia between different antihypertensive drug classes, with secondary outcomes of Alzheimer’s disease (AD) and vascular dementia (VaD). Adjusted Cox proportional hazards models with inverse probability of treatment weighting were used to generate results in each study site and were pooled in meta-analysis.
Results
One million nine hundred twenty-five thousand, five hundred sixty-three individuals were included across the four databases with a median follow-up ranging from 5.6 to 8.4 years. Compared to ACEI, initiation with ARB was associated with a reduced risk of incident all-cause dementia [hazard ratio (HR): 0.92, 95% confidence interval (CI): 0.89–0.94] and VaD (HR 0.87, 95% CI 0.78–0.96) but not AD.
Conclusions
This is the largest multinational cohort study conducted to date investigating different classes of antihypertensive drugs and the risk of incident dementia. When initiating antihypertensives, physicians and patients should consider the reduced risk of all-cause dementia and VaD with ARB compared with ACEI in their risk–benefit assessment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
- Research Department of Practice and Policy, UCL School of Pharmacy, London, UK.
- Centre for Medicines Optimisation Research and Education, University College London Hospitals NHS Foundation Trust, London, UK.
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
- Quality Use of Medicines and Pharmacy Research Centre, Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia.
- Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia.
ORCID-Profile: Edmund C L Cheung, Matthew Adesuyan, Máté Szilcz, Lisa M Kalisch Ellett, Yogini H Jani, Eric Yuk Fai Wan, Ian C K Wong, Kai-Hang Yiu, Celine S L Chui
Zitieren
APA
Cheung, E. C. L., Adesuyan, M., Szilcz, M., Kalisch Ellett, L. M., Shah, S., Jani, Y. H., Hägg, S., Pratt, N., Lau, K. K., Luo, H., Wan, E. Y. F., Chan, E. W. Y., Wong, I. C. K., Yuen, J. K., Yiu, K. H., Howard, R., Brauer, R., & Chui, C. S. L. (2025). Antihypertensive drug classes and risk of incident dementia: a multinational population-based cohort study. Age and Ageing. https://doi.org/10.1093/ageing/afaf121
Vancouver
Cheung ECL, Adesuyan M, Szilcz M, Kalisch Ellett LM, Shah S, Jani YH, et al. Antihypertensive drug classes and risk of incident dementia: a multinational population-based cohort study. Age and Ageing. 2025. doi:10.1093/ageing/afaf121
BibTeX
@article{Cheung2025,
author = {Cheung, Edmund C L and Adesuyan, Matthew and Szilcz, Máté and Kalisch Ellett, Lisa M and Shah, Sonia and Jani, Yogini H and Hägg, Sara and Pratt, Nicole and Lau, Kui Kai and Luo, Hao and Wan, Eric Yuk Fai and Chan, Esther Wai Yin and Wong, Ian C K and Yuen, Jacqueline K and Yiu, Kai-Hang and Howard, Robert and Brauer, Ruth and Chui, Celine S L},
title = {Antihypertensive drug classes and risk of incident dementia: a multinational population-based cohort study},
journal = {Age and Ageing},
year = {2025},
doi = {10.1093/ageing/afaf121}
}
EUVIMED